Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Customized Adjuvant Chemotherapy Based on BRCA1 Levels in NSCLC
NCT00478699Phase 3Completed
- Sponsor
- Fundación GECP
- Start
- Jun 2007
- Primary completion
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of docetaxel, cisplatin, gemcitabine in non-small cell lung cancer (NSCLC), sponsored by Fundación GECP. Started Jun 2007; status: completed.
02
Drugs
docetaxelcisplatingemcitabine
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00478699.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00478699.